AI-Powered Insight for Every Mammogram
CureMetrix (curemetrix.com) scores 79 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Technology brands, in the 71st percentile of 20931 Healthcare brands.
CureMetrix is a San Diego-based medical imaging company that develops FDA-cleared AI software for mammography. Its flagship product, cmAngio, helps radiologists detect, quantify, and contextualize breast arterial calcifications (BAC) on routine screening mammograms, turning a standard breast cancer screening into a dual-purpose exam. The software integrates into existing radiology workflows, aiming to provide more consistent, objective clinical insights. CureMetrix targets radiologists, breast imaging centers, hospitals, and healthcare providers seeking advanced AI tools for mammography interpretation and patient risk assessment.
| Brand Name | CureMetrix |
|---|---|
| Domain | curemetrix.com |
| Industry | Healthcare, Technology |
| Headquarters | San Diego |
| Main Competitors | iCAD (78/100), Volpara Health (75/100), Lunit (84/100), ScreenPoint Medical (66/100), Therapixel (78/100), Densitas, Hologic (90/100) |
Moz Domain Authority 32/100 vs category average 40 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Ranked #3,475,999 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "CureMetrix cmAngio® is FDA-cleared AI software for mammography that helps radiologists detect, quantify, and contextualize breast arterial calcifications (BAC) on routine screening…" (Meta description: 45 words. OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 2 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Next.js, Vercel.
Social footprint: verified profiles on LinkedIn, X (Twitter), Instagram, Facebook, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is CureMetrix?", Claude could identify the brand as of October 2026. CureMetrix is a healthcare AI company that develops computer-aided detection and diagnosis software for mammography, using machine learning to help radiologists spot breast cancer earlier and more accurately. Its flagship product, cmTriage/cmAssist, analyzes mammogram images to f Best known for AI-based mammography analysis software (cmAssist/cmTriage) for breast cancer detection.
When asked "Best brands similar to CureMetrix?", Claude would recommend CureMetrix as of October 2026. It's a recognized player in AI-driven breast cancer screening and would be relevant if someone asked about companies improving mammography diagnostics with machine learning.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
CureMetrix's main competitors in Healthcare: iCAD (78/100), Volpara Health (75/100), Lunit (84/100), ScreenPoint Medical (66/100), Therapixel (78/100).
Sources: Brand Analyzer scan
CureMetrix's primary product is cmAngio, an FDA-cleared AI software that detects, quantifies, and contextualizes breast arterial calcifications (BAC) on routine screening mammograms. It is designed to integrate into existing radiology workflows and provide expanded clinical insight from every mammogram beyond standard breast cancer screening.
Sources: CureMetrix official site
CureMetrix has limited AI-search visibility, scoring 33/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 39, recommendation 48). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: CureMetrix official site
CureMetrix is headquartered in San Diego. CureMetrix operates in the Healthcare category.
Sources: Wikidata
CureMetrix develops AI software for mammography, most notably cmAngio, which is FDA-cleared to detect, quantify, and contextualize breast arterial calcifications (BAC) on routine screening mammograms. The software integrates into existing radiology workflows, allowing a single mammogram to serve both breast cancer screening and cardiovascular risk assessment purposes by delivering objective clinical findings within seconds.
Sources: CureMetrix official site
CureMetrix scores 48/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: CureMetrix official site
CureMetrix is a medical imaging company based in San Diego that develops FDA-cleared artificial intelligence software for mammography analysis. The company's core focus is helping radiologists extract more clinical value from routine screening mammograms through AI-driven detection and quantification tools.
Sources: CureMetrix official site
CureMetrix can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: CureMetrix official site
CureMetrix is known for its cmAngio software, an FDA-cleared AI tool that identifies and quantifies breast arterial calcifications on standard screening mammograms, enabling a routine mammogram to provide additional cardiovascular risk insight alongside breast cancer screening.
Sources: CureMetrix official site
CureMetrix's software is used by radiologists, breast imaging centers, hospitals, and other healthcare providers who perform mammography and seek AI-assisted tools to enhance interpretation and expand clinical insight, including cardiovascular risk assessment through breast arterial calcification detection.
Sources: CureMetrix official site
CureMetrix scores 33/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
CureMetrix has a weak AI-visibility profile at 33/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (48/100) and its weakest is visibility (21/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #3,475,999 (Tranco) and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 32/100 and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify CureMetrix from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to CureMetrix: CultureLink (79/100), Cuideo (79/100), CureVac (79/100), Curium Pharma (79/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.